News & Insights
Contact Us
Databases
Services
Therapeutic Areas
Model Systems
Technologies
Service Type
About Us
Our Journey
Leadership Team
Core Values
Mission & Vision
JSR Life Sciences
Careers
Our Science
Resources
Blog
Contact Us
Blog
SHP2 and SOS1 Targets: Additional Players in the KRAS Inhibitors Race?
November 10, 2020
Search our Blog
Categories
ADCs
Alzheimer's
Antibodies
Biomarkers
Bladder Cancer
Blood Cancer
Breast Cancer
Cancer Stem Cells
CDX models
Cell Lines
Clinical Trials
Colorectal Cancer
Diabetes
Diagnostics
DNA Damage Response
Esophageal Cancer
GEMM Models
Glioblastoma
IBD
Imaging
Immuno-oncology
Inflammation
Liver Cancer
Lupus
Metastasis
MS
NGS
Head and Neck Cancer
Obesity
Oncogenes
Oncolytic Viruses
Organoids
Ovarian Cancer
Pancreatic Cancer
PARP inhibitors
PDX Models
PDXO Models
Pediatric Cancer
RAS proteins
Sequencing
Skin Cancer
Stomach Cancer
Syngeneic Models
Tumor Homograft
